Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2005
04/26/2005CA2103573C Stamen-specific promoters from rice
04/23/2005CA2446527A1 Method of rational-based drug design using osteocalcin
04/21/2005WO2005035773A2 Modified cea /b7 vector
04/21/2005WO2005035771A2 Nucleic acid constructs
04/21/2005WO2005035768A1 Expression of biologically active polypeptides in duckweed
04/21/2005WO2005035767A1 Alpha interferon variants
04/21/2005WO2005035765A1 Method of inhibiting interferon response
04/21/2005WO2005035763A1 Nucleotide sequences and polypeptides encoded thereby useful for producting transformed plants expressing lethal/nonviability genes
04/21/2005WO2005035762A1 Cytokine involved in epithelial-mesenchymal transition
04/21/2005WO2005035761A1 Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin
04/21/2005WO2005035760A2 Molecular nanomotor
04/21/2005WO2005035730A2 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
04/21/2005WO2005035722A2 Variant polypeptides containing plekstrin homology domains and uses therefor
04/21/2005WO2005035716A2 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof
04/21/2005WO2005035712A2 Methods and compositions for infectious cdna of sars coronavirus
04/21/2005WO2005035586A1 Fused protein composition
04/21/2005WO2005035585A1 Support having affinity for antibody
04/21/2005WO2005035579A1 A method for the treatment of maligant diseases by inhibiting nucleolin
04/21/2005WO2005035576A2 Method of resisting osteoclast formation
04/21/2005WO2005035571A1 Novel glycoprotein and medicinal composition containing the same
04/21/2005WO2005035570A2 Variants of cd40l protein
04/21/2005WO2005035569A2 Kiaa0779, splice variants thereof, and methods of their use
04/21/2005WO2005035568A1 Peptidomimetics and uses thereof
04/21/2005WO2005035567A1 Chimeric mhc protein and oligomer thereof for specific targeting
04/21/2005WO2005035566A1 Calcitonin peptides with reduced self aggregation activity
04/21/2005WO2005035565A1 Il-21 derivatives
04/21/2005WO2005035564A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/21/2005WO2005035563A1 Process for producing antithrombin iii composition
04/21/2005WO2005035562A1 Novel cell growth promoter
04/21/2005WO2005035561A1 Igf-i responsive gene and use thereof
04/21/2005WO2005035559A1 Isolated photoprotein mtclytin, and use thereof
04/21/2005WO2005035558A2 Piscirickettsia salmonis antigens and use thereof
04/21/2005WO2005035557A2 Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
04/21/2005WO2005035556A2 Sars-coronavirus virus-like particles and methods of use
04/21/2005WO2005035555A1 Hiv/siv env chimeras that promote trimerization and maintain targets of neutralizing antibodies
04/21/2005WO2005035553A2 Conjugation of peptides
04/21/2005WO2005035550A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier
04/21/2005WO2005035546A1 Peptide nucleic acid conjugates and uses thereof
04/21/2005WO2005035545A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences
04/21/2005WO2005034993A1 Vp1 fusion protein vaccin of recombinant foot-and-mouth disease virus
04/21/2005WO2005034992A2 Hiv vaccines based on env of multiple clades of hif
04/21/2005WO2005034988A1 Long-acting molecules in sustained release formulations
04/21/2005WO2005034984A1 Cd44 splice variant in diagnosis and therapy of intestinal cancer
04/21/2005WO2005034881A2 Methods and compositions for treating conditions involving abnormal angiogenesis
04/21/2005WO2005034877A2 G-csf transferrin fusion proteins
04/21/2005WO2005034853A2 Uses of interferons with altered spatial structure
04/21/2005WO2005034844A2 Exosite-directed thrombin inhibitors
04/21/2005WO2005034841A2 Anthrax vaccine
04/21/2005WO2005034733A2 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
04/21/2005WO2005034732A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
04/21/2005WO2005025310A3 MODEL SYSTEM FOR TCR ξ CHAIN DOWNREGULATION
04/21/2005WO2005017160A3 Mobilization of hematopoietic cells
04/21/2005WO2005014817A3 Chordin-like homologs
04/21/2005WO2005014631A9 Fungus resistant plants and their uses
04/21/2005WO2005012517A3 Use of the fret phenomenon for in vivo follow-up of biological events
04/21/2005WO2005012341A3 Pichia methanolica secretory signal
04/21/2005WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof
04/21/2005WO2005004910A3 Hcv vaccines
04/21/2005WO2005003776A3 In vitro methods for detecting renal cancer
04/21/2005WO2005003296A3 Albumin fusion proteins
04/21/2005WO2005000891A3 Thrombopoietin proteins with improved properties
04/21/2005WO2004113501A3 Methods and compositions relating to lipid accumulation
04/21/2005WO2004108142A3 Inhibitors of tip-1 for treatment tissue damage
04/21/2005WO2004094608A3 Human procolipase like nucleic acids and polypeptides and their methods of use threof
04/21/2005WO2004089982A3 April variants and methods thereof
04/21/2005WO2004087883A3 lovE VARIANT REGULATOR MOLECULES
04/21/2005WO2004087746A3 Staphylococcus epidermidis antigens
04/21/2005WO2004085473A3 Rgd-enriched gelatine-like proteins with enhanced cell binding
04/21/2005WO2004083388A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
04/21/2005WO2004081042A3 Identification of pain-relevant genes of a snsr family (specific sensory neurone receptors)
04/21/2005WO2004078918A3 Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
04/21/2005WO2004074507A3 Method to confer cell culture replication activity to different hepatitis c virus isolates
04/21/2005WO2004072256A3 Variants of cytochrome c and methods of diagnostics of thrombocytopenia
04/21/2005WO2004063327A3 F11 receptor(f11r) antagonists as therapeutic agents
04/21/2005WO2004060316A3 Irs modulators
04/21/2005WO2004058181A3 Vmp-like sequences of pathogenic borrelia species and strains
04/21/2005WO2004056080A9 Endothelial cell specifically binding peptides
04/21/2005WO2004053068A3 Protein modification and maintenance molecules
04/21/2005WO2004052273A3 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
04/21/2005WO2004020588A3 Transferrin fusion protein libraries
04/21/2005WO2004020581A3 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
04/21/2005WO2004018633A3 Abca13 nucleic acids and proteins, and uses thereof
04/21/2005WO2004018628A3 Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom
04/21/2005WO2004009802A3 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
04/21/2005WO2003102164A3 Cancer-linked gene as target for chemotherapy
04/21/2005WO2003097804A3 Promoter sequences for urocortin ii the use thereof
04/21/2005WO2003093418A3 Keratinocytes expressing exogenous angiogenic growth factors
04/21/2005WO2003091698A3 Cetp genetic markers for statin-specific changes in hdl cholesterol
04/21/2005WO2003076587A3 Cancer-linked gene as target for chemotherapy
04/21/2005WO2003067219A3 STRUCTURE OF INTEGRIN αV-β3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND
04/21/2005WO2003061559A3 Binding peptides specific for the extracellular domain of erbb2 and uses therefor
04/21/2005WO2003048339A3 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof
04/21/2005WO2003040330A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/21/2005WO2003016478A3 G-protein coupled receptor polynucleotides and methods of use thereof
04/21/2005WO2002098348A3 Glp-1 formulations with protracted time action
04/21/2005WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
04/21/2005WO2002090568A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/21/2005US20050086718 Plant transcriptional regulators of abiotic stress
04/21/2005US20050086716 Expression vector comprising nucleotide sequences coding sugary maize -2 gene (ISUM2A) for use as tool in generating transgenic crop plants with enhanced starch, plant oil or semolina production
04/21/2005US20050086715 Xenorhabdus nematophila DNA sequences induced within insects
1 ... 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 ... 2916